Table of Contents

1 Study Coverage

• 1.1 Dutasteride Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Dutasteride Market Size Growth Rate by Product
  • 1.4.2 Avodart
  • 1.4.3 Generic Avodart
• 1.5 Market by End User
  • 1.5.1 Global Dutasteride Market Size Growth Rate by End User
  • 1.5.2 Hospital
  • 1.5.3 Drug store
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Dutasteride Market Size
  • 2.1.1 Global Dutasteride Revenue 2014-2025
  • 2.1.2 Global Dutasteride Sales 2014-2025
• 2.2 Dutasteride Growth Rate by Regions
  • 2.2.1 Global Dutasteride Sales by Regions
  • 2.2.2 Global Dutasteride Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Dutasteride Sales by Manufacturers
  • 3.1.1 Dutasteride Sales by Manufacturers
  • 3.1.2 Dutasteride Sales Market Share by Manufacturers
  • 3.1.3 Global Dutasteride Market Concentration Ratio (CR5 and HHI)
• 3.2 Dutasteride Revenue by Manufacturers
  • 3.2.1 Dutasteride Revenue by Manufacturers (2014-2019)
  • 3.2.2 Dutasteride Revenue Share by Manufacturers (2014-2019)
• 3.3 Dutasteride Price by Manufacturers
• 3.4 Dutasteride Manufacturing Base Distribution, Product Types
  • 3.4.1 Dutasteride Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Dutasteride Product Type
  • 3.4.3 Date of International Manufacturers Enter into Dutasteride Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Dutasteride Sales by Product
• 4.2 Global Dutasteride Revenue by Product
• 4.3 Dutasteride Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Dutasteride Breakdown Data by End User

6 North America

• 6.1 North America Dutasteride by Countries
  • 6.1.1 North America Dutasteride Sales by Countries
  • 6.1.2 North America Dutasteride Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Dutasteride by Product
• 6.3 North America Dutasteride by End User

7 Europe

• 7.1 Europe Dutasteride by Countries
  • 7.1.1 Europe Dutasteride Sales by Countries
  • 7.1.2 Europe Dutasteride Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Dutasteride by Product
• 7.3 Europe Dutasteride by End User

8 Asia Pacific

• 8.1 Asia Pacific Dutasteride by Countries
  • 8.1.1 Asia Pacific Dutasteride Sales by Countries
  • 8.1.2 Asia Pacific Dutasteride Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Dutasteride by Product
• 8.3 Asia Pacific Dutasteride by End User

9 Central & South America

• 9.1 Central & South America Dutasteride by Countries
  • 9.1.1 Central & South America Dutasteride Sales by Countries
  • 9.1.2 Central & South America Dutasteride Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Dutasteride by Product
• 9.3 Central & South America Dutasteride by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Dutasteride by Countries
  • 10.1.1 Middle East and Africa Dutasteride Sales by Countries
  • 10.1.2 Middle East and Africa Dutasteride Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Dutasteride by Product
• 10.3 Middle East and Africa Dutasteride by End User

11 Company Profiles

• 11.1 GSK
  • 11.1.1 GSK Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 GSK Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 GSK Dutasteride Products Offered
  • 11.1.5 GSK Recent Development
• 11.2 Bionpharma
  • 11.2.1 Bionpharma Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Bionpharma Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Bionpharma Dutasteride Products Offered
  • 11.2.5 Bionpharma Recent Development
• 11.3 Rising Pharmaceuticals
  • 11.3.1 Rising Pharmaceuticals Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Rising Pharmaceuticals Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Rising Pharmaceuticals Dutasteride Products Offered
  • 11.3.5 Rising Pharmaceuticals Recent Development
• 11.4 Teva
  • 11.4.1 Teva Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Teva Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Teva Dutasteride Products Offered
  • 11.4.5 Teva Recent Development
• 11.5 Mylan
  • 11.5.1 Mylan Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Mylan Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Mylan Dutasteride Products Offered
  • 11.5.5 Mylan Recent Development
• 11.6 Zydus
  • 11.6.1 Zydus Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Zydus Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Zydus Dutasteride Products Offered
  • 11.6.5 Zydus Recent Development
• 11.7 Amneal Pharma
  • 11.7.1 Amneal Pharma Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Amneal Pharma Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Amneal Pharma Dutasteride Products Offered
  • 11.7.5 Amneal Pharma Recent Development
• 11.8 Apotex
  • 11.8.1 Apotex Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Apotex Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Apotex Dutasteride Products Offered
  • 11.8.5 Apotex Recent Development
• 11.9 Marksans Pharma
  • 11.9.1 Marksans Pharma Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Marksans Pharma Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Marksans Pharma Dutasteride Products Offered
  • 11.9.5 Marksans Pharma Recent Development
• 11.10 Breckenridge Pharmaceutical
  • 11.10.1 Breckenridge Pharmaceutical Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Breckenridge Pharmaceutical Dutasteride Products Offered
  • 11.10.5 Breckenridge Pharmaceutical Recent Development

12 Future Forecast

• 12.1 Dutasteride Market Forecast by Regions
  • 12.1.1 Global Dutasteride Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Dutasteride Revenue Forecast by Regions 2019-2025
• 12.2 Dutasteride Market Forecast by Product
  • 12.2.1 Global Dutasteride Sales Forecast by Product 2019-2025
  • 12.2.2 Global Dutasteride Revenue Forecast by Product 2019-2025
• 12.3 Dutasteride Market Forecast by End User
• 12.4 North America Dutasteride Forecast
• 12.5 Europe Dutasteride Forecast
• 12.6 Asia Pacific Dutasteride Forecast
• 12.7 Central & South America Dutasteride Forecast
• 12.8 Middle East and Africa Dutasteride Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Dutasteride Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.
The global Dutasteride market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dutasteride market based on company, product type, end user and key regions.

This report studies the global market size of Dutasteride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dutasteride in these regions.
This research report categorizes the global Dutasteride market by top players/brands, region, type and end user. This report also studies the global Dutasteride market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GSK
Bionpharma
Rising Pharmaceuticals
Teva
Mylan
Zydus
Amneal Pharma
Apotex
Marksans Pharma
Breckenridge Pharmaceutical

Market size by Product
Avodart
Generic Avodart
Market size by End User
Hospital
Drug store

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Dutasteride market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dutasteride market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dutasteride companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dutasteride submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Dutasteride are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dutasteride market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.